The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ankle Measurements of Arterial Pressure: Semi-recumbent or Horizontal Position. (2PAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06032169
Recruitment Status : Completed
First Posted : September 11, 2023
Last Update Posted : January 9, 2024
Sponsor:
Information provided by (Responsible Party):
Nantes University Hospital

Brief Summary:
The upper arm is sometimes inaccessible for arterial pressure (AP) measurement. Placing the automatic cuff at the ankle is a common alternative. However, whether AP measurement at the ankle is reliable is uncertain. Furthermore, it is unknown whether it is necessary to place the patient in a horizontal position to improve the reliability of the measurement, or if leaving the patient in default position (often semi-recumbent) is acceptable. The aim of this study is to answer these questions. Additionally, investigators will evaluate whether a smartphone application that allows for the simple measurement of AP (by gently placing a finger on the camera lens) is a valuable alternative to upper arm measurements.

Condition or disease Intervention/treatment
Intensive Care Unit Arterial Catheter Other: Patients of a surgical intensive care unit having an arterial catheter

Detailed Description:

A question that arises relatively frequently is "when the upper arm is inaccessible, where should the investigators place the automatic cuff to measure AP?". Indeed, surgical intervention involving the upper limb, a wound, a fracture, or vascular access (temporary catheter or arteriovenous fistula) often makes the arm unsuitable for monitoring AP with an automatic cuff. The arterial catheter is not devoid of risks (including the loss of precious time for its insertion) and is rarely an appropriate alternative, at least in the first instance. Thus, the inaccessibility of the upper arm legitimates the frequent placement of the automatic cuff at the ankle. However, the automatic cuff has only been validated for placement at the upper arm, not at the ankle. Surprisingly, the reliability of ankle AP measurements obtained by this positioning of the cuff at the ankle has been little studied: only two studies, using arterial catheter as the reference method, are available, one of which was in the specific population of patients with obesity. These studies reported that the measurement error at the ankle was excessive, but confirmation is necessary.

Patients, especially in acute care settings, are rarely in a strictly horizontal supine position. For various reasons, the critically ill patient is rather in a semi-recumbent position, meaning that the angle between the trunk and the horizontal axis is between 30 and 60°. Thus, the cuff placed at the ankle is no longer at the level of the heart and more precisely of the phlebostatic axis. This could modify the hydrostatic pressure and lead to overestimation of AP compared to a measurement of AP at heart level (on the arm or invasively, for example). Indeed, the impact on AP measurement of the height of the upper arm relative to the heart has already been demonstrated: the vertical displacement of the upper arm changes the measured AP value. Does the angle of elevation of the trunk significantly modify the AP measured at the ankle? If so, and since the measurement at the ankle in the horizontal supine position (0°) tends to underestimate AP, do the different sources of measurement error "cancel out" in the semi-recumbent position? In what position of the trunk is it preferable to measure AP at the ankle? The answers to these questions are uncertain. Indeed, the only study that investigators are aware of (a pilot study) and that specifically addressed this issue did not provide clear answers. This is important since AP is a crucial parameter of monitoring and therefore of therapeutic decision-making. It is remarkable that in acute care settings, little to no attention is paid to trunk elevation when measuring BP at the ankle, and of course, there is no automation of patient positioning (e.g., in a horizontal position) prior to each automatic measurement at the ankle.

Therefore, it appears important to evaluate the accuracy and precision of non-invasive ankle measurements of AP and the impact of patient position on it. This will be the main objective of the study. If these ankle measurements prove to be neither accurate nor precise, having an alternative would be desirable. It is noteworthy that when the arm is inaccessible, the finger often is. AP measurement at the finger is now possible with a simple smartphone. This finger measurement requires calibration with one or two automatic cuff measurements, which should be possible in most cases (the arm is frequently inaccessible for prolonged AP monitoring, but still allows for one or two isolated measurements). So, which is the better alternative site for AP measurement, the finger or ankle? AP measurement using a smartphone has never been evaluated from this perspective. This will be a secondary objective of the study.

Layout table for study information
Study Type : Observational
Actual Enrollment : 51 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: NON-INVASIVE MEASUREMENT OF ARTERIAL PRESSURE AT THE ANKLE: IMPACT OF POSITION, SEMI-RECUMBENT OR HORIZONTAL. A SINGLE-CENTER PROSPECTIVE STUDY.
Actual Study Start Date : October 4, 2023
Actual Primary Completion Date : December 18, 2023
Actual Study Completion Date : December 18, 2023

Intervention Details:
  • Other: Patients of a surgical intensive care unit having an arterial catheter
    Patients of a surgical intensive care unit having an arterial catheter undergoing noninvasive measurements of AP in the two studied positions (semi-recumbent or horizontal).


Primary Outcome Measures :
  1. To evaluate whether the non-invasive measurement error of ankle mean Arterial Pressure is acceptable in either patient position (semi-recumbent or horizontal). [ Time Frame: 15 minutes ]

    The measurement error will be considered acceptable if the current international standard, the AAMI/ESH/ISO standard, is met: mean error (bias) ≤ 5.0 mmHg and its standard deviation ≤ 8.0 mmHg.

    The reference AP will be measured using an arterial catheter, taking advantage of the fact that many critically ill patients already have one.



Secondary Outcome Measures :
  1. To evaluate whether the non-invasive measurement error of ankle systolic and diastolic Arterial Pressure is acceptable in either patient position (semi-recumbent or horizontal). [ Time Frame: 15 minutes ]
    The AAMI/ESH/ISO standard will indicate if the reliability is acceptable: mean error (bias) ≤ 5.0 mmHg and its standard deviation ≤ 8.0 mmHg.

  2. To evaluate whether the non-invasive measurement error of mean, systolic and diastolic Arterial Pressure at the upper arm is acceptable in either patient position (semi-recumbent or horizontal). [ Time Frame: 15 minutes ]
    The AAMI/ESH/ISO standard will indicate if the reliability is acceptable: mean error (bias) ≤ 5.0 mmHg and its standard deviation ≤ 8.0 mmHg.

  3. To evaluate whether the non-invasive measurement error of mean, systolic and diastolic Arterial Pressure with a smartphone is acceptable. [ Time Frame: 15 minutes ]
    The AAMI/ESH/ISO standard will indicate if the reliability is acceptable: mean error (bias) ≤ 5.0 mmHg and its standard deviation ≤ 8.0 mmHg.

  4. To evaluate the risk associated with measurement errors of systolic and mean Arterial Pressure with each technique at each position. [ Time Frame: 15 minutes ]
    Via a dedicated error grid, the risk associated with measurement errors was classified into one of the 5 risk levels ranging from "no risk" to "dangerous risk". Distribution across the different risk levels was compared by Fisher exact tests.

  5. To evaluate the ability of noninvasive measurements to detect hypo-/hypertension. [ Time Frame: 15 minutes ]
    The ability of averaged noninvasive measurements to detect hypotension (invasive mean Arterial Pressure <65 mmHg, systolic Arterial Pressure <90 mmHg), hypertension (invasive mean Arterial Pressure >100 mmHg, systolic Arterial Pressure >140 mmHg), and a significant therapy-induced change in invasive mean Arterial Pressure (>10%) was determined through area under the receiver operating characteristic curve (AUCROC) analysis.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patients of a surgical intensive care unit having an arterial catheter.
Criteria

Inclusion Criteria :

  • Patients having a catheter in the radial artery.
  • and with stable AP over a 5-min period (no change in invasive mean AP >10% and no change in vasoactive drugs)

Exclusion Criteria :

  • Cardiac arrhythmia.
  • Dysfunction of the arterial catheter and/or waveform suggesting an over- or an under-damping.
  • Arm circumference > 42 cm (measured at mid-arm).
  • Contraindication to AP measurement at the arm (fracture, wound, amputated limb, limb ischemia, infection, phlebitis, history of lymph node dissection, venous access used on this limb and contraindicating inflation, other).
  • Contraindication to the horizontal supine position or to the semi-recumbent position, even transiently.
  • Patient's health condition requiring urgent care that is incompatible with the study protocol.
  • Asymmetry of mean AP between the two upper arms (> 5 mmHg) or inability to assess it.
  • Pregnancy.
  • Age <18 years old.
  • Adult known to be under guardianship or curatorship before inclusion.
  • Absence of coverage by the French national health insurance (Sécurité sociale).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06032169


Locations
Layout table for location information
France
Nantes University Hospital
Nantes, Loire-Atlantique, France, 44093
Sponsors and Collaborators
Nantes University Hospital
Layout table for additonal information
Responsible Party: Nantes University Hospital
ClinicalTrials.gov Identifier: NCT06032169    
Other Study ID Numbers: RC23_0233
First Posted: September 11, 2023    Key Record Dates
Last Update Posted: January 9, 2024
Last Verified: January 2024
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Nantes University Hospital:
Ankle
Calf
Blood pressure determination
Catheterization, Peripheral / methods
Cuff
Oscillometry